| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.59 | 3e-58 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-13 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-10 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |